Virax Biolabs Rings the Nasdaq Stock Market Closing Bell

Virax Biolabs Group Limited (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection and diagnosis of viral diseases, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, James Foster, Chairman of the Board and Chief Executive Officer, rings the Closing Bell.